by BA Warady 2024Purpose: Limited information exists on the use of any intravenous iron preparation in pediatric HD patients. Ferrlecit prescribing
Feraheme [prescribing information]. Waltham, MA: AMAG Pharmaceuticals, Inc.; June 2024. 2. Ferrlecit [prescribing information]. Bridgewater
Ferrlecit is supplied in a single use am _____ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Ferrlecit safely and effectively. See full prescribing information for Ferrlecit. Ferrlecit (sodium ferric gluconate complex in sucrose injection), For intravenous (IV) use Initial U.S
Please visit hikma.com/us for additional product information, including the Full Prescribing Information with complete FERRLECIT. Antianemic. Clear
dosing information and administration options. See Full Prescribing Safety Info Ferrlecit (sodium ferric gluconate complex in sucrose injection)
Ferrlecit. Package insert. sanofi-aventis U.S. LLC; 2024. INFeD PRESCRIBING INFORMATION; IMPORTANT SAFETY INFORMATION. TERMS AND CONDITIONS
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Ferrlecit safely and effectively. See full prescribing information for Ferrlecit. Ferrlecit (sodium ferric gluconate complex in sucrose injection), for intravenous use Initial U.S. Approval: 2024
prescribing information. Iron content and SFG apparent molecular weight were Ferrlecit and its approved generic copy on the U.S. market. The
MEMBER PRESCRIBER INFORMATION: Authorization may be delayed if incomplete. ❑ Feraheme (ferumoxytol). ❑ Ferrlecit (sodium ferric gluconate complex).
Comments